Literature DB >> 32619110

Silencing Stat3 inhibits viability and induces apoptosis in BGC-823 human gastric cancer cell line.

Yaming Xu1, Shini Feng2, Bing Niu2.   

Abstract

Gastric cancer (GC) is characterized by infrequent early diagnosis, poor prognosis and high mortality. Signal transducer and activator of transcription 3 (Stat3) and signal transducer and activator of transcription 5b (Stat5b) play multiple roles in the development and progression of many human cancers. We investigated the effects of silencing Stat3 and Stat5b on the viability and apoptosis of the human gastric cancer cell line, BGC-823. We found that Stat3 and Stat5b were expressed in both the nucleus and cytoplasm of BGC-823 cells. Silencing of Stat3 caused significantly decreased viability and increased apoptosis, as well as attenuated B-cell lymphoma-2 (Bcl-2) expression in BGC-823 cells. Silencing of Stat5b, however, had no significant effect on these events. Stat3, but not Stat5b, plays an important role in the viability and apoptosis of human gastric cancer cell line, BGC-823, which suggests that Stat3 is a potential target for gastric cancer therapy.

Entities:  

Keywords:  Apoptosis; BGC-823 cell line; RNA interference; Stat3; Stat5b; gastric cancer; human; viability

Mesh:

Substances:

Year:  2020        PMID: 32619110     DOI: 10.1080/10520295.2020.1770332

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  2 in total

1.  Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF-MS/MS and network pharmacology.

Authors:  Xiaona Lu; Yawei Zheng; Fang Wen; Wenjie Huang; Xiaoxue Chen; Shuai Ruan; Suping Gu; Yue Hu; Yuhao Teng; Peng Shu
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

2.  LncRNA RPSAP52 promotes cell proliferation and inhibits cell apoptosis via modulating miR-665/STAT3 in gastric cancer.

Authors:  Chao He; Yuanyuan Liu; Jinhou Li; Xiao Zheng; Jianwei Liang; Gang Cui; Hong Chang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.